Arkadios Wealth Advisors Global Blood Therapeutics, Inc. Transaction History

Arkadios Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$24.9 - $40.26 $12,450 - $20,130	-500 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$32.46 - $43.42 $6,492 - $8,684	200 Added 66.67%	500 $17,000
Q4 2020 Feb 09, 2021	BUY	$37.65 - $63.77 $5,647 - $9,565	150 Added 100.0%	300 $12,000
Q3 2020 Nov 10, 2020	BUY	$52.76 - $74.49 $7,914 - $11,173	150 New	150 $9.44 Million
Q2 2020 Aug 10, 2020	SELL	$48.73 - $81.82 $3,654 - $6,136	-75 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $3,427 - $6,139	75 New	75 $5,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.